Clinical outcome of pretreated B-cell chronic lymphocytic leukemia following alemtuzumab therapy: a retrospective study on various cytogenetic risk categories
ANNALS OF ONCOLOGY
Fiegl, M; Erdel, M; Tinhofer, I; Brychtova, Y; Panovska, A; Doubek, M; Eigenberger, K; Fonatsch, C; Hopfinger, G; Muhlberger, H; Zabernigg, A; Falkner, F; Gastl, G; Mayer, J; Greil, R, 2010: Clinical outcome of pretreated B-cell chronic lymphocytic leukemia following alemtuzumab therapy: a retrospective study on various cytogenetic risk categories. ANNALS OF ONCOLOGY 21(12), p. 2410 - 2419, doi: 10.1093/annonc/mdq236
CEITEC authors: